Literature DB >> 29985328

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration.

Eveliina Pollari1, Robert Prior1, Wim Robberecht2, Philip Van Damme2, Ludo Van Den Bosch3.   

Abstract

Assessing the functionality of the nerve axon provides detailed information on the progression of neuromuscular disorders. Electrophysiological recordings provide a sensitive approach to measure nerve conduction in humans and rodent models. To broaden the technical possibilities for electromyography in mice, the measurement of compound muscle action potentials (CMAPs) from the brachial plexus nerve in the forelimb using needle electrodes is described here. CMAP recordings after stimulating the sciatic nerve in hindlimbs have been previously described. The newly introduced method here allows for the evaluation of the nerve conductivity at an additional site, and thus provides a more profound overview of the neuromuscular functionality. The technique provides information on both the relative number of functional axons and the myelination level. Thereby, this method can be applied to assess both axonal diseases as well as demyelinating conditions. This minimally invasive method does not require extraction of the nerve and therefore it is suitable for repeated measurements for longitudinal follow-up in the same animal. Similar recordings are performed in clinical setups to emphasize the translational relevance of the method.

Entities:  

Mesh:

Year:  2018        PMID: 29985328      PMCID: PMC6101751          DOI: 10.3791/57741

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Surface vs. fine-wire electrode ensemble-averaged signals during gait.

Authors:  W C Jacobson; R H Gabel; R A Brand
Journal:  J Electromyogr Kinesiol       Date:  1995-03       Impact factor: 2.368

2.  Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice.

Authors:  C Huxley; E Passage; A M Robertson; B Youl; S Huston; A Manson; D Sabéran-Djoniedi; D Figarella-Branger; J F Pellissier; P K Thomas; M Fontés
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

3.  Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations.

Authors:  J Zielasek; R Martini; K V Toyka
Journal:  Muscle Nerve       Date:  1996-08       Impact factor: 3.217

4.  Dorsal caudal tail and sciatic motor nerve conduction studies in adult mice: technical aspects and normative data.

Authors:  Robin H Xia; Nejla Yosef; Eroboghene E Ubogu
Journal:  Muscle Nerve       Date:  2010-06       Impact factor: 3.217

5.  Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice.

Authors:  Amit K Srivastava; Samantha R Renusch; Nicole E Naiman; Shuping Gu; Amita Sneh; W David Arnold; Zarife Sahenk; Stephen J Kolb
Journal:  Neurobiol Dis       Date:  2012-04-11       Impact factor: 5.996

6.  Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.

Authors:  K M Krajewski; R A Lewis; D R Fuerst; C Turansky; S R Hinderer; J Garbern; J Kamholz; M E Shy
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

Review 7.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

8.  In vivo electrophysiological measurements on mouse sciatic nerves.

Authors:  Alexander Schulz; Christian Walther; Helen Morrison; Reinhard Bauer
Journal:  J Vis Exp       Date:  2014-04-13       Impact factor: 1.355

9.  Electrophysiological Biomarkers in Spinal Muscular Atrophy: Preclinical Proof of Concept.

Authors:  W David Arnold; Paul N Porensky; Vicki L McGovern; Chitra C Iyer; Sandra Duque; Xiaobai Li; Kathrin Meyer; Leah Schmelzer; Brian K Kaspar; Stephen J Kolb; John T Kissel; Arthur H M Burghes
Journal:  Ann Clin Transl Neurol       Date:  2014-01-01       Impact factor: 4.511

10.  Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease.

Authors:  Veronick Benoy; Pieter Vanden Berghe; Matthew Jarpe; Philip Van Damme; Wim Robberecht; Ludo Van Den Bosch
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

View more
  2 in total

1.  Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.

Authors:  Chuansheng Zhang; Abhijeet Joshi; Yanhong Liu; Ozlem Sert; Seth G Haddix; Lindsay H Teliska; Anne Rasband; George G Rodney; Matthew N Rasband
Journal:  Curr Biol       Date:  2021-07-20       Impact factor: 10.900

2.  AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1.

Authors:  Burcak Ozes; Morgan Myers; Kyle Moss; Jennifer Mckinney; Alicia Ridgley; Lei Chen; Shasha Bai; Charles K Abrams; Mona M Freidin; Jerry R Mendell; Zarife Sahenk
Journal:  Gene Ther       Date:  2021-02-04       Impact factor: 5.250

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.